Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma

Thyroid carcinoma, a disease in which malignant cells form in the thyroid tissue, is the most common endocrine carcinoma, with papillary thyroid carcinoma (PTC) accounting for nearly 80% of total thyroid carcinoma cases. However, the management of metastatic or recurrent therapy-refractory PTC is ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seok-Mo, Park, Keunwan, Lim, Jin Hong, Yun, Hyeok Jun, Kim, Sang Yong, Choi, Kyung Hwa, Kim, Chan Wung, Lee, Jae Ha, Weicker, Raymond, Pan, Cheol-Ho, Park, Ki Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499486/
https://www.ncbi.nlm.nih.gov/pubmed/36142303
http://dx.doi.org/10.3390/ijms231810378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499486/
https://www.ncbi.nlm.nih.gov/pubmed/36142303
http://dx.doi.org/10.3390/ijms231810378

Ejemplares similares